From Symptom To Strategy: Transforming Oncology Trials With Next-Gen eCOA

Understanding the patient experience is essential in oncology research, and electronic Clinical Outcome Assessments (eCOA)—especially electronic Patient-Reported Outcomes (ePROs)—play a vital role in capturing this perspective. Medable’s oncology-focused eCOA platform empowers researchers to gather meaningful, real-world data by supporting novel digital endpoints, long-term follow-up, and workflows aligned with regulatory requirements. This session explores how sponsors and sites can enhance trial execution by leveraging protocol-ready libraries and user-friendly assessment tools designed with both patient and caregiver needs in mind.

Follow along with practical guidance on designing protocols that incorporate digital endpoints and LTFU for maximum data value and regulatory alignment. The session also highlights proven strategies for reducing operational complexity at clinical sites through efficient eCOA deployment. Finally, learn how digital-first methodologies can boost trial engagement, improve the site experience, and accelerate trial timelines from initiation through closeout.